{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:27:33Z","timestamp":1794490053583,"version":"4.9.1"},"publisher-location":"New York, NY","reference-count":42,"publisher":"Springer New York","isbn-type":[{"value":"9781493918034","type":"print"},{"value":"9781493918041","type":"electronic"}],"license":[{"start":{"date-parts":[[2014,11,8]],"date-time":"2014-11-08T00:00:00Z","timestamp":1415404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,11,8]],"date-time":"2014-11-08T00:00:00Z","timestamp":1415404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1007\/978-1-4939-1804-1_12","type":"book-chapter","created":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T12:49:30Z","timestamp":1417438170000},"page":"235-247","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Methylation Profile Landscape in Mesothelioma: Possible Implications in Early Detection, Disease Progression, and Therapeutic Options"],"prefix":"10.1007","author":[{"given":"Xinbo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naimei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun K.","family":"Rishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey I.","family":"Pass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Wali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,8]]},"reference":[{"key":"12_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/carcin\/bgp220","volume":"31","author":"S Sharma","year":"2010","unstructured":"Sharma S, Kelly TK, Jones PA (2010) Epigenetics in cancer. Carcinogenesis 31:27\u201336","journal-title":"Carcinogenesis"},{"key":"12_CR2","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/nbt.1685","volume":"28","author":"A Portela","year":"2010","unstructured":"Portela A, Esteller M (2010) Epigenetic modifications and human disease. Nat Biotechnol 28:1057\u20131068","journal-title":"Nat Biotechnol"},{"key":"12_CR3","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1056\/NEJMra072067","volume":"358","author":"M Esteller","year":"2008","unstructured":"Esteller M (2008) Epigenetics in cancer. N Engl J Med 358:1148\u20131159","journal-title":"N Engl J Med"},{"key":"12_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.lungcan.2013.05.014","volume":"81","author":"F Vandermeers","year":"2013","unstructured":"Vandermeers F, Sriramareddy SN, Costa C, Hubaux R, Cosse JP, Willems L (2013) The role of epigenetics in malignant pleural mesothelioma. Lung Cancer 81:311\u2013318","journal-title":"Lung Cancer"},{"key":"12_CR5","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.ctrv.2012.12.005","volume":"39","author":"J Remon","year":"2013","unstructured":"Remon J, Lianes P, Martinez S, Velasco M, Querol R, Zanui M (2013) Malignant mesothelioma: new insights into a rare disease. Cancer Treat Rev 39:584\u2013591","journal-title":"Cancer Treat Rev"},{"key":"12_CR6","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1056\/NEJMra050152","volume":"353","author":"BW Robinson","year":"2005","unstructured":"Robinson BW, Lake RA (2005) Advances in malignant mesothelioma. N Engl J Med 353:1591\u20131603","journal-title":"N Engl J Med"},{"issue":"Suppl 5","key":"12_CR7","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1289\/ehp.97105s51073","volume":"105","author":"MC Jaurand","year":"1997","unstructured":"Jaurand MC (1997) Mechanisms of fiber-induced genotoxicity. Environ Health Perspect 105(Suppl 5):1073\u20131084","journal-title":"Environ Health Perspect"},{"key":"12_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/bjc.1986.158","volume":"54","author":"KT Kelsey","year":"1986","unstructured":"Kelsey KT, Yano E, Liber HL, Little JB (1986) The in vitro genetic effects of fibrous erionite and crocidolite asbestos. Br J Cancer 54:107\u2013114","journal-title":"Br J Cancer"},{"key":"12_CR9","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1165\/ajrcmb\/9.2.186","volume":"9","author":"M Yegles","year":"1993","unstructured":"Yegles M, Saint-Etienne L, Renier A, Janson X, Jaurand MC (1993) Induction of metaphase and anaphase\/telophase abnormalities by asbestos fibers in rat pleural mesothelial cells in vitro. Am J Respir Cell Mol Biol 9:186\u2013191","journal-title":"Am J Respir Cell Mol Biol"},{"key":"12_CR10","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/carcin\/bgn059","volume":"29","author":"BC Christensen","year":"2008","unstructured":"Christensen BC, Godleski JJ, Marsit CJ, Houseman EA, Lopez-Fagundo CY, Longacker JL, Bueno R, Sugarbaker DJ, Nelson HH, Kelsey KT (2008) Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma. Carcinogenesis 29:1555\u20131559","journal-title":"Carcinogenesis"},{"key":"12_CR11","first-page":"3341","volume":"17","author":"AN Bagwe","year":"1997","unstructured":"Bagwe AN, Kay PH, Spagnolo DV (1997) Evidence that DNA methylation imbalance is not involved in the development of malignant mesothelioma. Anticancer Res 17:3341\u20133343","journal-title":"Anticancer Res"},{"key":"12_CR12","doi-asserted-by":"publisher","first-page":"5686","DOI":"10.1158\/0008-5472.CAN-10-0190","volume":"70","author":"BC Christensen","year":"2010","unstructured":"Christensen BC, Houseman EA, Poage GM, Godleski JJ, Bueno R, Sugarbaker DJ, Wiencke JK, Nelson HH, Marsit CJ, Kelsey KT (2010) Integrated profiling reveals a global correlation between epigenetic and genetic alterations in mesothelioma. Cancer Res 70:5686\u20135694","journal-title":"Cancer Res"},{"key":"12_CR13","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1158\/0008-5472.CAN-08-2586","volume":"69","author":"BC Christensen","year":"2009","unstructured":"Christensen BC, Houseman EA, Godleski JJ, Marsit CJ, Longacker JL, Roelofs CR, Karagas MR, Wrensch MR, Yeh RF, Nelson HH, Wiemels JL, Zheng S, Wiencke JK, Bueno R, Sugarbaker DJ, Kelsey KT (2009) Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome. Cancer Res 69:227\u2013234","journal-title":"Cancer Res"},{"key":"12_CR14","first-page":"423","volume":"24","author":"H Kohno","year":"2010","unstructured":"Kohno H, Amatya VJ, Takeshima Y, Kushitani K, Hattori N, Kohno N, Inai K (2010) Aberrant promoter methylation of WIF-1 and SFRP1, 2, 4 genes in mesothelioma. Oncol Rep 24:423\u2013431","journal-title":"Oncol Rep"},{"key":"12_CR15","first-page":"1265","volume":"20","author":"K Kimura","year":"2008","unstructured":"Kimura K, Toyooka S, Tsukuda K, Yamamoto H, Suehisa H, Soh J, Otani H, Kubo T, Aoe K, Fujimoto N, Kishimoto T, Sano Y, Pass HI, Date H (2008) The aberrant promoter methylation of BMP3b and BMP6 in malignant pleural mesotheliomas. Oncol Rep 20:1265\u20131268","journal-title":"Oncol Rep"},{"key":"12_CR16","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/ijc.22341","volume":"120","author":"K Tomii","year":"2007","unstructured":"Tomii K, Tsukuda K, Toyooka S, Dote H, Hanafusa T, Asano H, Naitou M, Doihara H, Kisimoto T, Katayama H, Pass HI, Date H, Shimizu N (2007) Aberrant promoter methylation of insulin-like growth factor binding protein-3 gene in human cancer. Int J Cancer 120:566\u2013573","journal-title":"Int J Cancer"},{"key":"12_CR17","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.bbrc.2006.02.084","volume":"342","author":"S Batra","year":"2006","unstructured":"Batra S, Shi Y, Kuchenbecker KM, He B, Reguart N, Mikami I, You L, Xu Z, Lin YC, Cl\u00e9ment G, Jablons DM (2006) Wnt inhibitory factor-1, a Wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesothelioma. Biochem Biophys Res Commun 342:1228\u20131232","journal-title":"Biochem Biophys Res Commun"},{"key":"12_CR18","doi-asserted-by":"publisher","first-page":"6672","DOI":"10.1038\/sj.onc.1207881","volume":"23","author":"AY Lee","year":"2004","unstructured":"Lee AY, He B, You L, Dadfarmay S, Xu Z, Mazieres J, Mikami I, McCormick F, Jablons DM (2004) Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma. Oncogene 23:6672\u20136676","journal-title":"Oncogene"},{"key":"12_CR19","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1158\/0008-5472.743.65.3","volume":"65","author":"B He","year":"2005","unstructured":"He B, Lee AY, Dadfarmay S, You L, Xu Z, Reguart N, Mazieres J, Mikami I, McCormick F, Jablons DM (2005) Secreted frizzled-related protein 4 is silenced by hypermethylation and induces apoptosis in beta-catenin-deficient human mesothelioma cells. Cancer Res 65:743\u2013748","journal-title":"Cancer Res"},{"key":"12_CR20","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.lungcan.2007.06.015","volume":"58","author":"JA Tsou","year":"2007","unstructured":"Tsou JA, Galler JS, Wali A, Ye W, Siegmund KD, Groshen S, Laird PW, Turla S, Koss MN, Pass HI, Laird-Offringa IA (2007) DNA methylation profile of 28 potential marker loci in malignant mesothelioma. Lung Cancer 58:220\u2013230","journal-title":"Lung Cancer"},{"key":"12_CR21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.lungcan.2006.06.017","volume":"54","author":"JR Fischer","year":"2006","unstructured":"Fischer JR, Ohnmacht U, Rieger N, Zemaitis M, Stoffregen C, Kostrzewa M, Buchholz E, Manegold C, Lahm H (2006) Promoter methylation of RASSF1A, RARbeta and DAPK predict poor prognosis of patients with malignant mesothelioma. Lung Cancer 54:109\u2013116","journal-title":"Lung Cancer"},{"key":"12_CR22","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.lungcan.2007.08.035","volume":"59","author":"A Destro","year":"2008","unstructured":"Destro A, Ceresoli GL, Baryshnikova E, Garassino I, Zucali PA, De Vincenzo F, Bianchi P, Morenghi E, Testori A, Alloisio M, Santoro A, Roncalli M (2008) Gene methylation in pleural mesothelioma: correlations with clinico-pathological features and patient\u2019s follow-up. Lung Cancer 59:369\u2013376","journal-title":"Lung Cancer"},{"key":"12_CR23","doi-asserted-by":"publisher","first-page":"9073","DOI":"10.1158\/0008-5472.CAN-09-1595","volume":"69","author":"Y Goto","year":"2009","unstructured":"Goto Y, Shinjo K, Kondo Y, Shen L, Toyota M, Suzuki H, Gao W, An B, Fujii M, Murakami H, Osada H, Taniguchi T, Usami N, Kondo M, Hasegawa Y, Shimokata K, Matsuo K, Hida T, Fujimoto N, Kishimoto T, Issa JP, Sekido Y (2009) Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma. Cancer Res 69:9073\u20139082","journal-title":"Cancer Res"},{"key":"12_CR24","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.lungcan.2010.05.008","volume":"71","author":"LS Kristensen","year":"2011","unstructured":"Kristensen LS, Nielsen HM, Hager H, Hansen LL (2011) Methylation of MGMT in malignant pleural mesothelioma occurs in a subset of patients and is associated with the T allele of the rs16906252 MGMT promoter SNP. Lung Cancer 71:130\u2013136","journal-title":"Lung Cancer"},{"key":"12_CR25","doi-asserted-by":"publisher","first-page":"19478","DOI":"10.1074\/jbc.M110.217331","volume":"286","author":"L Nocchi","year":"2011","unstructured":"Nocchi L, Tomasetti M, Amati M, Neuzil J, Santarelli L, Saccucci F (2011) Thrombomodulin is silenced in malignant mesothelioma by a poly(ADP-ribose)polymerase-1-mediated epigenetic mechanism. J Biol Chem 286:19478\u201319488","journal-title":"J Biol Chem"},{"key":"12_CR26","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.bbrc.2009.12.095","volume":"391","author":"KV Kosuri","year":"2010","unstructured":"Kosuri KV, Wu X, Wang L, Villalona-Calero MA, Otterson GA (2010) An epigenetic mechanism for capecitabine resistance in mesothelioma. Biochem Biophys Res Commun 391:1465\u20131470","journal-title":"Biochem Biophys Res Commun"},{"key":"12_CR27","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1016\/S0959-8049(00)00303-8","volume":"36","author":"M Esteller","year":"2000","unstructured":"Esteller M (2000) Epigenetic lesions causing genetic lesions in human cancer: promoter hypermethylation of DNA repair genes. Eur J Cancer 36:2294\u20132300","journal-title":"Eur J Cancer"},{"key":"12_CR28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrc1279","volume":"4","author":"AP Feinberg","year":"2004","unstructured":"Feinberg AP, Tycko B (2004) The history of cancer epigenetics. Nat Rev Cancer 4:143\u2013153","journal-title":"Nat Rev Cancer"},{"key":"12_CR29","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1242\/jcs.010389","volume":"120","author":"H Donninger","year":"2007","unstructured":"Donninger H, Vos MD, Clark GJ (2007) The RASSF1A tumor suppressor. J Cell Sci 120:3163\u20133172","journal-title":"J Cell Sci"},{"key":"12_CR30","doi-asserted-by":"publisher","first-page":"4632","DOI":"10.1200\/JCO.2004.07.151","volume":"22","author":"PM Das","year":"2004","unstructured":"Das PM, Singal R (2004) DNA methylation and cancer. J Clin Oncol 22:4632\u20134642","journal-title":"J Clin Oncol"},{"key":"12_CR31","doi-asserted-by":"publisher","first-page":"6080","DOI":"10.1158\/0008-5472.CAN-06-0157","volume":"66","author":"J Furuta","year":"2006","unstructured":"Furuta J, Nobeyama Y, Umebayashi Y, Otsuka F, Kikuchi K, Ushijima T (2006) Silencing of Peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas. Cancer Res 66:6080\u20136086","journal-title":"Cancer Res"},{"key":"12_CR32","doi-asserted-by":"publisher","first-page":"190","DOI":"10.2174\/1874467210902020190","volume":"2","author":"M Tomasetti","year":"2009","unstructured":"Tomasetti M, Amati M, Santarelli L, Alleva R, Neuzil J (2009) Malignant mesothelioma: biology, diagnosis and therapeutic approaches. Curr Mol Pharmacol 2:190\u2013206","journal-title":"Curr Mol Pharmacol"},{"key":"12_CR33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/PAT.0b013e3283445e67","volume":"43","author":"SC Kao","year":"2011","unstructured":"Kao SC, Reid G, van Zandwijk N, Henderson DW, Klebe S (2011) Molecular biomarkers in malignant mesothelioma: state of the art. Pathology 43:201\u2013212","journal-title":"Pathology"},{"key":"12_CR34","first-page":"50","volume":"2010","author":"L Wild","year":"1806","unstructured":"Wild L, Flanagan JM (1806) Genome-wide hypomethylation in cancer may be a passive consequence of transformation. Biochim Biophys Acta 2010:50\u201357","journal-title":"Biochim Biophys Acta"},{"key":"12_CR35","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/bies.201000061","volume":"32","author":"C Mund","year":"2010","unstructured":"Mund C, Lyko F (2010) Epigenetic cancer therapy: proof of concept and remaining challenges. Bioessays 32:949\u2013957","journal-title":"Bioessays"},{"key":"12_CR36","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.lungcan.2009.01.015","volume":"66","author":"S Amatori","year":"2009","unstructured":"Amatori S, Papalini F, Lazzarini R, Donati B, Bagaloni I, Rippo MR, Procopio A, Pelicci PG, Catalano A, Fanelli M (2009) Decitabine, differently from DNMT1 silencing, exerts its antiproliferative activity through p21 upregulation in malignant pleural mesothelioma (MPM) cells. Lung Cancer 66:184\u2013190","journal-title":"Lung Cancer"},{"key":"12_CR37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ctrv.2009.09.003","volume":"36","author":"GL Ceresoli","year":"2010","unstructured":"Ceresoli GL, Zucali PA, Gianoncelli L, Lorenzi E, Santoro A (2010) Second-line treatment for malignant pleural mesothelioma. Cancer Treat Rev 36:24\u201332","journal-title":"Cancer Treat Rev"},{"key":"12_CR38","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.cellsig.2011.02.003","volume":"23","author":"J Ren","year":"2011","unstructured":"Ren J, Singh BN, Huang Q, Li Z, Gao Y, Mishra P, Hwa YL, Li J, Dowdy SC, Jiang SW (2011) DNA hypermethylation as a chemotherapy target. Cell Signal 23:1082\u20131093","journal-title":"Cell Signal"},{"key":"12_CR39","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1158\/1078-0432.CCR-10-2986","volume":"17","author":"M Takenouchi","year":"2011","unstructured":"Takenouchi M, Hirai S, Sakuragi N, Yagita H, Hamada H, Kato K (2011) Epigenetic modulation enhances the therapeutic effect of anti-IL13R(alpha)2 antibody in human mesothelioma xenografts. Clin Cancer Res 17:2819\u20132829","journal-title":"Clin Cancer Res"},{"key":"12_CR40","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cell.2013.03.004","volume":"153","author":"WG Kaelin","year":"2013","unstructured":"Kaelin WG, McKnight SL (2013) Influence of metabolism on epigenetics and disease. Cell 153:56\u201369","journal-title":"Cell"},{"key":"12_CR41","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/0-387-28274-2_12","volume-title":"Malignant mesothelioma: advances in pathogenesis, diagnosis, and translational therapies","author":"A Wali","year":"2005","unstructured":"Wali A, Pass HI (2005) Genomics and proteomics in mesothelioma. In: Pass HI, Vogelzang NJ, Carbone M (eds) Malignant mesothelioma: advances in pathogenesis, diagnosis, and translational therapies. Springer, New York, pp 186\u2013206"},{"key":"12_CR42","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1126\/science.1246755","volume":"342","author":"ST Furey","year":"2013","unstructured":"Furey ST, Sethupathy P (2013) Genetics driving epigenetics. Science 342:705\u2013706","journal-title":"Science"}],"container-title":["Methods in Molecular Biology","Cancer Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-1804-1_12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T10:54:25Z","timestamp":1676890465000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-4939-1804-1_12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,8]]},"ISBN":["9781493918034","9781493918041"],"references-count":42,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-1804-1_12","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4939-1804-1","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,8]]},"assertion":[{"value":"8 November 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}